(Dimethylamino)acetaldehyde Diethyl Acetal CAS 3616-56-6 Ịdị Ọcha>99.0% (GC) Afatinib Dimaleate Intermediate Factory

Nkọwa dị mkpirikpi:

Aha: (Dimethylamino) acetaldehyde Diethyl Acetal

Okwu ndị yiri: 2,2-Diethoxy-N, N-Dimethylethylamine

Isi: 3616-56-6

Dị ọcha:> 99.0% (GC)

Ọdịdị: Liquid doro anya na-enweghị agba

Nke etiti Afatinib Dimaleate (CAS: 850140-73-7)

Ogo dị elu, mmepụta azụmahịa

E-Mail: alvin@ruifuchem.com


Nkọwa ngwaahịa

Ngwaahịa ndị emetụtara

Mkpado ngwaahịa

Nkọwa:

Njirimara kemịkalụ:

Aha Chemical (Dimethylamino) acetaldehyde Diethyl Acetal
Ụdị okwu 2,2-Diethoxy-N, N-Dimethylethylamine;N- (2,2-Diethoxyethyl) dimethylamine;2,2-Diethoxy-N,N-Dimethylethan-1-Amine
Nọmba CAS 3616-56-6
Nọmba CAT RF-PI2031
Ọnọdụ Ahịa N'ọkwa, Mpụta Ihe ruru Tọn
Usoro ihe omimi C8H19NO2
Ibu molekụla 161.25
Mmetụta Mmiri nwere mmetụta
Ebe esi nri 60 ℃/5 mmHg
Ebe mgbari 45 ℃
Ụdị Ruifu Chemical

Nkọwapụta:

Ihe Nkọwapụta
Ọdịdị Mmiri doro anya enweghị agba
Ụzọ ịdị ọcha / nyocha > 99.0% (GC)
Ntụgharị ntụgharị N20/D 1.410-1.414
Nnukwu ike ndọda (20/20 ℃) 0.865-0.870
Ọnụ ego nke Proton NMR Spectrum Dabara na Ọdịdị
Mgbakọta adịghị ọcha <1.00%
Ọla dị arọ (dị ka Pb) ≤20ppm
Nlele ọkọlọtọ Standardkpụrụ ụlọ ọrụ
Ojiji Ndị n'etiti ọgwụ;Afatinib Dimaleate;Sumatriptan

Ngwungwu & Nchekwa:

ngwugwu: Klas Fluorinated, 25kg/Drum, ma ọ bụ dị ka ndị ahịa chọrọ

Ọnọdụ Nchekwa:Na-echekwa n'ime akpa ndị a kpuchiri ekpuchi na ebe dị jụụ na nke kpọrọ nkụ;Chebe site na ìhè na mmiri mmiri

Uru:

1

Ajụjụ:

Ngwa:

(Dimethylamino) acetaldehyde Diethyl Acetal (CAS: 3616-56-6) na-eji dị ka ọgwụ intermediates.(Dimethylamino) acetaldehyde Diethyl Acetal nwere ike iji mee ihe na njikọ nke Afatinib Dimaleate (CAS: 850140-73-7), Sumatriptan (CAS: 103628-46-2).Afatinib (aha ahia Gilotrif na US na Giotrif na Europe, nke mbụ Tomtovok na Tovok) bụ ọgwụ akwadoro na United States, Europe, Taiwan, Mexico, Chile na Japan yana mba ndị ọzọ maka ọgwụgwọ mbụ nke ndị ọrịa nwere iche. ụdị metastatic (EGFR mutation positive) nke na-abụghị obere cell lung carcinoma (NSCLC), nke Boehringer Ingelheim mepụtara.Afatinib na-arụ ọrụ dị ka onye na-egbochi onye na-eme ihe na-adịghị agbanwe agbanwe nke tyrosine kinases epidermal growth factor receptor (EGFR) na erbB-2 (HER2).Sumatriptan bụ triptan mbụ akwadoro (1991) maka nnukwu ọgwụgwọ isi ọwụwa migraine.Ọ nwere bioavailability dị ala n'etiti triptans niile n'ihi obere lipophilicity ya.Nnweta nke ọtụtụ usoro dosage dị iche iche (ya bụ, mbadamba ụrọ, injection SC, usoro ịgba imi, na ọgwụ suppository) na-enye ohere mgbanwe nke ịkwa akwa maka mkpa nke onye ọrịa n'otu n'otu, na-eme ka sumatriptans bụrụ ọgwụ bara uru maka nnukwu ọgwụgwọ migraine. isi ọwụwa.Sumatriptan nwekwara ngwa ngwa ngwa ngwa site na ntụtụ SC ma ọ bụ nchịkwa imi.

Dee ozi gị ebe a ziga anyị ya